Clinical Trial Update: Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions [NA]

View source ↗

Summary

Clinical trial update on dose de-escalation of prostate radiotherapy using MR-Linac delivered in two fractions; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Prostate Cancer (Adenocarcinoma) | NA | Status: RECRUITING